melanoma
75 projects
FP7Individual fellowship2014–2016Spain
METABOSET · Unraveling metabolic settings and targeting metabolic enzymes with selective lethality in BRAF and NRAS mutant melanoma tumors
FP7Individual fellowship2013–2015United Kingdom
ImageMelTherapyLRI · Single cell level intravital imaging of response, tolerance, and resistance to targeted therapies
2 partners
FP7Individual fellowship2013–2015Netherlands
LISCOMF · Light-induced spatiotemporal control of membrane fusion for targeted therapy
FP7Individual fellowship2013–2015United Kingdom
Radiopharm Metal Iso · New chemical platforms for targeted radiopharmaceuticals based on generator-produced metal isotopes
FP7Individual fellowship2012–2015France
MELENDO2 · Genetic epidemiological investigation into the association between endometriosis and cutaneous melanoma
FP7Reintegration grant2012–2016Italy
STEMIMMUNE · Improving adoptive T cell transfer immunotherapy for cancer with T memory stem cells
FP7Individual fellowship2012–2014Switzerland
LCMVACC · Prophylactic and therapeutic use of recombinant lymphocytic choriomeningitis virus against melanoma
FP7Individual fellowship2011–2013United Kingdom
Melanoma Invasion · Molecular mechanisms of melanoma invasion
FP7Staff exchange2009–2013Ireland
TARGET-MELANOMA · Molecular Dissection of Melanoma Progression: An integrated Pan-European Approach
9 partners · 5 countries
FP7Reintegration grant2008–2012Israel
ROLE OF TCR AFFINITY · Study and modification of T-cell receptor structure to enhance anti-tumor activity
FP6Individual fellowship2007–2009France
CANCERBIOMECHANICS · Biomechanical modeling of tumor growth in oncology
FP6Individual fellowship2006–2008Netherlands
PROTEUS · The role of the intracellular peptidases in the immune system and in the cellular metabolism
FP6Reintegration grant2006–2007Spain
MOUSE MELANOMA MODEL · Characterization of novel acting mechanisms of the Hepatocyte Growth Factor (HGF) in melanomagenesis: Bring into play the HGF transgenic animal model
FP6Reintegration grant2005–2007Hungary
DNA DAMAGE BYPASS · Regulation and mechanism of replication of damaged DNA: role of yeast and human Rad5 and ubiquitylation
FP6Individual fellowship2005–2007United Kingdom
CLECT-X · Functional characterization of a novel C-type lectin receptor differentially expressed in CD8alpha+ dendritic cells
FP6Individual fellowship2005–2006Germany
ATTACC · Dendritic cell-based cancer immunotherapy targeting the tumour stroma
2 partners · 2 countries
FP6Excellence award2005–2009France
HUMPROTHER · New tools for delivering therapeutic proteins: application to human therapy
FP6Staff exchange2005–2009Ireland
DIAGNOMICS · Proteomics and functional genomics in diagnostic target discovery
3 partners · 3 countries
FP6Individual fellowship2005–2006Austria
RANK AND BREAST CANC · The Role of RANK and RANKL in breast cancer and metastasis generation of new mouse model for breast cancer research
FP6Individual fellowship2005–2007France
EPISPREAD_XP · Cellular And Molecular Mechanisms Of Cross-Presentation In Epitope Spreading Following Immune Responses To Anti-Tumor Vaccines
FP6Individual fellowship2004–2006Italy
METINHIB · A MET-TARGETED TYROSINE KINASE INHIBITORAS A NEW ANTICANCER DRUG
FP6Individual fellowship2004–2006Spain
TEL-MM · Mouse models to analyse the role of telomerase in cancer and aging
FP5Training site2002–2006Austria
Advanced conformal radiotherapy - stereotactic radiotherapy and intensity modulated radiotherapy
FP5Individual fellowship2001–2002Unknown Region